Circa
Executive Summary
Settles class action civil suit brought by customers alleging damages from the company's marketing of a fraudulent generic version of SmithKline Beecham's Dyazide. Circa (formerly Bolar) will pay $1.4 mil. into a settlement fund and will issue $2.5 mil. in coupons for Circa products to settle the suit